Sarcopenia as a Risk Factor for Alzheimer’s Disease: Genetic and Epigenetic Perspectives
Genes,
Journal Year:
2024,
Volume and Issue:
15(5), P. 561 - 561
Published: April 27, 2024
Sarcopenia,
defined
as
the
age-associated
loss
of
muscle
mass
and
increased
fragility
with
age,
is
increasing
worldwide.
The
condition
often
precedes
development
Alzheimer’s
disease,
thereby
decreasing
levels
mobility
physical
activity
in
those
affected.
Indeed,
has,
some
studies,
been
associated
an
risk
disease
other
dementias.
However,
a
detailed
understanding
interplay
between
both
conditions
not
available
needs
to
be
thoroughly
addressed.
In
following
review,
we
focus
on
several
genes,
specifically
APOE,
BDNF,
ACE,
FTO,
FNDC5,
that
have
conditions.
We
also
discuss
epigenetic
regulation
each
these
genes
along
non-coding
RNAs
(ncRNAs)
may
role
sarcopenic
phenotypes.
Finally,
assert
application
systems
biology
will
unravel
relationship
sarcopenia
believe
prevention
older
age
reduce
incidence
debilitating
cognitive
decline.
Language: Английский
“Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”
Garima Sharma,
No information about this author
Badruddeen Badruddeen,
No information about this author
Juber Akhtar
No information about this author
et al.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 23, 2025
Language: Английский
Biomarkers in Alzheimer’s disease: new frontiers with olfactory models
Shubhrat Maheshwari,
No information about this author
Aditya Vikram Singh,
No information about this author
Amita Verma
No information about this author
et al.
Inflammopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 1, 2025
Language: Английский
Understanding the Molecular Impact of Physical Exercise on Alzheimer’s Disease
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13576 - 13576
Published: Dec. 18, 2024
Alzheimer’s
disease
is
one
of
the
most
common
neurodegenerative
diseases,
characterized
by
a
wide
range
neurological
symptoms
that
begin
with
personality
changes
and
psychiatric
symptoms,
progress
to
mild
cognitive
impairment,
eventually
lead
dementia.
Physical
exercise
part
non-pharmacological
treatments
used
in
disease,
as
it
has
been
shown
delay
process
improving
redox
state
brain
tissue,
providing
anti-inflammatory
effects
or
stimulating
release
brain-derived
neurotrophic
factor
enhances
structure
performance.
Here,
we
reviewed
results
obtained
from
studies
conducted
both
animal
models
human
subjects
comprehend
how
physical
interventions
can
exert
molecular
mechanisms
underlying
pathophysiological
processes
disease:
amyloid
β-peptide
pathology,
tau
neuroglial
changes,
mitochondrial
dysfunction,
oxidative
stress.
seems
have
protective
effect
against
since
induce
positive
some
biomarkers
related
disease.
However,
additional
humans
are
necessary
address
current
lack
conclusive
evidence.
Language: Английский
Pharmacokinetic Assessments of Ursolic Loaded-Dendrimer Complex
Current Pharmaceutical Analysis,
Journal Year:
2024,
Volume and Issue:
20(7), P. 538 - 556
Published: Aug. 29, 2024
Background:
This
study
investigates
the
application
of
polyamidoamine
(PAMAM)
dendrimers
as
an
innovative
drug
delivery
approach
for
enhancing
pharmacokinetic
profile
ursolic
acid
(UA),
a
pentacyclic
triterpenoid
with
multifaceted
therapeutic
properties.
UA,
sourced
from
plants
like
Sanguisorba
officinalis
and
Salvia
officinalis,
has
been
extensively
studied
its
pharmacological
characteristics,
including
anti-inflammatory,
antioxidant,
anti-diabetic
properties,
recognized
in
Traditional
Chinese
Medicine
(TCM).
The
clinical
utility
UA
is
hampered
by
low
bioavailability,
which
attributed
to
hydrophobic
nature.
To
address
this
limitation,
we
explore
use
PAMAM
dendrimers,
known
their
potential.
Methods:
UA-PAMAM
G0
were
synthesized
varying
molar
ratios.
Characterization
included
size
analysis,
PDI,
zeta
potential
determination.
FTIR
confirmed
chemical
structure.
Male
SD
rats
acclimatized
administered
control
suspension
UA-G0
dendrimer
complex
orally.
Blood
samples
collected
analysis.
obtained
IAEC
approval.
Results:
complexes
exhibited
sizes
based
on
ratios,
2:1
ratio
showing
significantly
smaller
dimensions.
successful
conjugation.
In
study,
demonstrated
higher
plasma
concentrations
than
alone,
indicated
increased
Cmax
AUC
values.
results
suggest
enhanced
oral
bioavailability
complex.
Conclusion:
synthesis
variations
analysis
revealed
improved
compared
alone.
These
findings
highlight
compounds
bridging
gap
between
traditional
herbal
medicine
modern
strategies.
Further
research
can
broader
applications
such
systems.
Language: Английский